Answers are grounded in this paper and cite their sources.
Helper lipids are essential structural components of lipid nanoparticles (LNPs), yet systematic design principles linking helper lipid architecture to messenger RNA (mRNA) delivery performance remain poorly defined. Here we identify helper lipid architecture as a major, largely unexplored design lever for optimizing LNP performance. Using a modular library of more than 80 rationally designed helper lipids, we show that systematic variation in headgroup chemistry, linker topology, and tail cardinality reshapes both LNP biophysical behavior and biological performance. Martini molecular dynamics (MD) simulations combined with multimodal structural analyses reveal that high-performing scaffolds undergo a pH-dependent transition into fusogenic inverse hexagonal-like ordering, substantially lowering the energetic barrier for endosomal escape. These performance gains persist across the clinically relevant ALC-0315 and DLin-MC3-DMA platforms, establishing helper lipid architecture as a transferable design parameter across distinct ionizable lipid chemistries. Translating these design principles into function, optimized helper lipid formulations restore hepatic protein expression in a mouse model of ornithine transcarbamylase (OTC) deficiency and increase antigen expression and immunogenicity in both preclinical models and in the in vitro human MIMIC platform. Together, these findings establish helper lipids as tunable molecular actuators of potency, tolerability, and stability, offering an engineering framework for next-generation mRNA vaccines and therapeutics.
No takes yet. Share an insight, caveat, or question.
Karve et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: